Pharis Mohideen - Nov 22, 2021 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Role: Chief Medical Officer
Signature: /s/ Jason Minio, Attorney-in-Fact
Stock symbol: DBVT
Transactions as of: Nov 22, 2021
Transactions value $: $0
Form type: 4
Date filed: 11/24/2021, 03:13 PM
Next filing: Aug 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBVT	Ordinary Shares	Award	$0	+8.7K	+56.13%	$0.00	24.2K	Nov 22, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DBVT	Employee Stock Option (right to buy)	Award	$0	+95.4K		$0.00	95.4K	Nov 22, 2021	Ordinary Shares	95.4K	$6.62	Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share.
F2	Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 22, 2022, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
F3	This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1278 to EURO 1.00 as of November 22, 2021.
F4	25% of the shares subject to the option vest on November 22, 2022, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.